George Somlo
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name George Somlo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:01 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03100877 · Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple MyelomaCity of Hope Medical Center · withdrawn · Plasma Cell Leukemia in Remission, Plasma Cell Myeloma · principal investigator
- N/ANCT01231386 · MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast CancerCity of Hope Medical Center · completed · Breast Cancer · principal investigator
- Ph2NCT00810797 · Exemestane in Treating Postmenopausal Women With Stage IV Breast CancerCity of Hope Medical Center · completed · Breast Cancer · principal investigator
- Ph2NCT00182793 · Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerCity of Hope Medical Center · completed · Breast Cancer · principal investigator
- Ph1/Ph2NCT00112827 · Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple MyelomaCity of Hope Medical Center · completed · Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma · principal investigator
- Ph1/Ph2NCT00086957 · Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast CancerCity of Hope Medical Center · completed · Breast Cancer · principal investigator
- Ph2NCT00002601 · Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With SarcomaCity of Hope Medical Center · completed · Sarcoma · study chair
- Ph1NCT00002854 · High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerCity of Hope Medical Center · completed · Cancer · study chair
- Ph2NCT00003042 · Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast CancerCity of Hope Medical Center · completed · Breast Cancer · principal investigator
- Ph2NCT00004088 · Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple MyelomaCity of Hope Medical Center · completed · Multiple Myeloma and Plasma Cell Neoplasm · principal investigator
- Ph2NCT00004092 · Combination Chemotherapy in Treating Patients With High-Risk Breast CancerCity of Hope Medical Center · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026Named on NCT00810797, NCT00182793, NCT00086957, NCT00002601, NCT00002854, NCT00003042, NCT00004088, NCT00004092
- U01CA063265RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00004092
Most cited trial papers
Clinical-trial papers with this author name in multiple myeloma, ranked by citations from NIH iCite, fetched 2026-11-12 12:01 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- 537 citationsRCR 14.4
- 318 citationsRCR 7.1
- 221 citationsRCR 5.2
- Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.J Clin Oncol · 2019219 citationsRCR 8.5
- A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.Br J Haematol · 2013138 citationsRCR 3.7
- Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.Int J Radiat Oncol Biol Phys · 2009117 citationsRCR 3.5
- An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.Clin Lymphoma Myeloma Leuk · 2012106 citationsRCR 2.6
- 66 citationsRCR 1.7
- Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma.Clin Cancer Res · 201143 citationsRCR 1.3
- Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study.Lancet Haematol · 202141 citationsRCR 2.1